Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001381370 | SCV001579736 | pathogenic | Mucopolysaccharidosis, MPS-III-A | 2024-03-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val253Cysfs*11) in the SGSH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGSH are known to be pathogenic (PMID: 11182930, 21204211, 22976768). This variant is present in population databases (rs760281672, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with SGSH-related conditions. ClinVar contains an entry for this variant (Variation ID: 1069492). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001820081 | SCV002064168 | pathogenic | not provided | 2024-03-14 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD) |
Baylor Genetics | RCV001381370 | SCV004201086 | pathogenic | Mucopolysaccharidosis, MPS-III-A | 2023-10-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001381370 | SCV005653282 | likely pathogenic | Mucopolysaccharidosis, MPS-III-A | 2024-06-17 | criteria provided, single submitter | clinical testing |